FDA · 新闻稿·· 28 天前精选AI 评分47
三星Bioepis首个新药候选获快速通道资格
The first new drug candidate being developed by Samsung Bioepis has been designated as a fast track - 매일경제
AI 导读
据매일경제报道,三星Bioepis正在开发的首个新药候选已获快速通道资格认定。原文未披露该药物的名称、适应症及认定机构。
来源:FDA · 新闻稿 · news.google.com